Bailey John E. (Jack) Jr.

President and CEO at G1 Therapeutics, Inc.

Sold, on record
$923k
Dollars the filings state
Form 4 sales
7
Latest Jul 5, 2024
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale G1 Therapeutics, Inc.Plan not stated
    Jan 3 2022

    Sold 34,125 shares at $10.41 ($355k)

    Bailey John E. (Jack) Jr., President and CEO

    Sold 12.8% of holdings ($2.8M position)233,208 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale G1 Therapeutics, Inc.Plan not stated
    Jan 4 +366 days

    Sold 37,626 shares at $5.81 ($219k)

    Bailey John E. (Jack) Jr., President and CEO

    Sold 12% of holdings ($1.8M position)276,282 shares leftFiling

  3. 3 Form 4 sale G1 Therapeutics, Inc.Routine
    Jul 5 +182 days

    Sold 2,719 shares at $2.45 ($7k)

    Bailey John E. (Jack) Jr., President and CEO

    10b5-1 planSold 0.6% of holdings ($1.1M position)433,563 shares leftFiling

  4. 4 Form 4 sale G1 Therapeutics, Inc.No plan
    Jan 2 +181 days

    Sold 32,983 shares at $3.27 ($108k)

    Bailey John E. (Jack) Jr., President and CEO

    No 10b5-1 planSold 7.6% of holdings ($1.4M position)400,580 shares left1x usual sizeFiling

  5. 5 Form 4 sale G1 Therapeutics, Inc.No plan
    Jan 3 +1 day

    Sold 11,686 shares at $3.12 ($36k)

    Bailey John E. (Jack) Jr., President and CEO

    No 10b5-1 planSold 2.3% of holdings ($1.6M position)489,594 shares left0.3x usual sizeFiling

  6. 6 Form 4 sale G1 Therapeutics, Inc.No plan
    May 13 +131 days

    Sold 37,258 shares at $4.79 ($178k)

    Bailey John E. (Jack) Jr., President and CEO

    No 10b5-1 planSold 7.6% of holdings ($2.3M position)452,336 shares left1.7x usual sizeFiling

  7. 7 Form 4 sale G1 Therapeutics, Inc.No plan
    Jul 5 +53 days

    Sold 7,662 shares at $2.51 ($19k)

    Bailey John E. (Jack) Jr., President and CEO

    No 10b5-1 planSold 1.4% of holdings ($1.4M position)549,674 shares left0.2x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (7)

Form 144 notices and Form 4 sales by Bailey John E. (Jack) Jr.
Source
Jul 5, 2024G1 Therapeutics, Inc.President and CEOForm 4 sale7,662$19k1.4%No planSEC
May 13, 2024G1 Therapeutics, Inc.President and CEOForm 4 sale37,258$178k7.6%No planSEC
Jan 3, 2024G1 Therapeutics, Inc.President and CEOForm 4 sale11,686$36k2.3%No planSEC
Jan 2, 2024G1 Therapeutics, Inc.President and CEOForm 4 sale32,983$108k7.6%No planSEC
Jul 5, 2023G1 Therapeutics, Inc.President and CEOForm 4 sale2,719$7k0.6%RoutineSEC
Jan 4, 2023G1 Therapeutics, Inc.President and CEOForm 4 sale37,626$219k12.0%Plan not statedSEC
Jan 3, 2022G1 Therapeutics, Inc.President and CEOForm 4 sale34,125$355k12.8%Plan not statedSEC